Brief: Brainstorm Cell Therapeutics Inc- Are Exploring Various Strategies To Secure Necessary Funding
20/12/2023 14:06
Dec 20 (Reuters) - Brainstorm Cell Therapeutics Inc
BCLI.O :
* BRAINSTORM CELL THERAPEUTICS INC- ARE EXPLORING VARIOUS
STRATEGIES TO SECURE NECESSARY FUNDING
* BRAINSTORM CELL THERAPEUTICS INC- INTEND TO SEEK A SPECIAL
PROTOCOL ASSESSMENT WHICH COULD SIGNIFICANTLY DE-RISK REGULATORY
ASPECTS OF NUROWN PROGRAM
* BRAINSTORM CELL THERAPEUTICS INC- ANTICIPATE MAKING
SUBMISSION
OF SPA REQUEST IN FEBRUARY 2024
Source text for Eikon: ID:nPn9F7CTha
Further company coverage: BCLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview